GENOTECH CORP.
(주)제노텍
Verification summary
- Legal name (EN / KO)
- GENOTECH CORP. ((주)제노텍)
- Business registration no.
314-81-19334(3148119334)- Stock listing
- KONEX listed · stock code
066830· DART00393618 - 12-month KONEPS contracts
3contracts · KRW 333,547,500- Live NTS tax status
- Check live NTS status ↗
- verified_at
How to verify a Korean company (BRN format, live NTS status, DART & KONEPS) →
- English name (as registered with DART)
- GENOTECH CORP.
- Korean legal name
- (주)제노텍
- Alternate names
- 제노텍
- Market
KONEX- Stock Code
066830- DART Corp Code
00393618- CEO
- 김재종
- Business Registration No.
314-81-19334- Corporate Registration No.
1601110064157- Established Date
1997-07-08- Fiscal Month
12- KSIC Industry Code
204- Address (KO)
- 대전광역시 유성구 가정북로 26-69
- Homepage
- https://www.genotech.co.kr/ ↗
English names are as registered with DART and may differ from the Korean legal name. Use corp_code, stock_code, or business registration number to identify a company.
2026-11-01 04:14 UTCAnnual Financial Summary
Annual report standard financial summary not available (newly listed or financial-sector account structure).
2026-11-01 04:14 UTCRecent DART Filings (Last 90 Days, up to 20)
| Filed | Theme | Filing (EN) | Filer |
|---|---|---|---|
| No filings in the last 90 days. | |||
Data from Korea's Financial Supervisory Service (OpenDART). FSS does not guarantee accuracy or completeness. Figures as filed, in the currency shown (usually KRW). Not investment advice. English names are as registered with DART and may differ from the Korean legal name. Use corp_code, stock_code, or business registration number to identify a company.
2026-11-01 04:14 UTCPublic procurement (last 12 months)
Contracts first signed in the last 12 months.
The 12-month window is by original contract signing date: it covers contracts first signed in the period, and excludes amendments registered in the period to contracts signed earlier. Amounts are in KRW from Korea's Public Procurement Service (KONEPS). The 12-month total counts sole contracts in full and joint contracts by the supplier's share; joint contracts without a published share are counted but not summed. Multi-year contracts count only the current-period amount. Unit-price (framework) contracts are reported separately because their values are ceilings, not spend. Where KONEPS reports no total contract amount, the current-period amount is used as the total.
- Aggregation Period
2025-11-08to2026-11-07(basis:original_signed_date)- 12-Month Procurement Amount
- KRW 333,547,500
- 12-Month Contract Count
3(Joint contracts:0)- Unit-Price (Framework) Contracts (Reported Separately)
1contracts | Ceiling: KRW 202,142,600
By Procurement Category
| Category | Contracts | 12M Counted Amount (KRW) |
|---|---|---|
| Goods (물품) | 0 | KRW 0 |
| Construction (공사) | 0 | KRW 0 |
| Services (용역) | 3 | KRW 333,547,500 |
| Foreign Procurement (외자) | 0 | KRW 0 |
By Contract Type
| Contract Type | Contracts | Supplier Share / Current Amount (KRW) | Total Contract Ceiling / Multi-year Total (KRW) |
|---|---|---|---|
| Lump-sum / Standard (총액·일반) | 2 | KRW 333,547,500 | KRW 333,547,500 |
| Multi-year / Continuing (장기·계속비) | 0 | KRW 0 | KRW 0 |
| Unit-price / Framework Ceiling (단가·제3자단가 — excluded from 12M total) | 1 | KRW 202,142,600 | KRW 202,142,600 |
| Unclassified / Zero-amount (기타) | 0 | KRW 0 | KRW 0 |
Top 5 Government Buyers
| Buyer (Korean Legal Name) | Agency Code | Contracts | 12M Amount (KRW) |
|---|---|---|---|
| 질병관리청 | 1790387 | 1 | KRW 189,876,500 |
| 국립낙동강생물자원관 | B553508 | 1 | KRW 143,671,000 |
| 오송첨단의료산업진흥재단 | Z021937 | 1 | KRW 0 |
Recent Contracts (up to 3)
| Signed Date | Contract No. (KONEPS) | Contract Title (KO) | Category / Type | Buyer (KO) | Contract Amount (KRW) | Participation |
|---|---|---|---|---|---|---|
| 2026-05-29 | R26TA01913688 ↗ |
2026년 수탁과제 유전자분석(일반시퀀싱 등 5항목) | services / lump_sum |
국립낙동강생물자원관 | KRW 143,671,000 | Sole (100%) |
| 2026-04-15 | R26TA01750143 ↗ |
2026년 단가계약(유전자서열분석 및 올리고 합성) | services / unit_price |
오송첨단의료산업진흥재단 | KRW 202,142,600 | Sole (100%) |
| 2025-12-02 | R25TA01156674 ↗ |
[연구,030] 카바페넴분해효소생성장내세균목(CPE) 감염증 진단을 위한 아형 분석 | services / lump_sum |
질병관리청 | KRW 189,876,500 | Sole (100%) |